This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

Mitoxantrone injection USP (2014-11-21)

Starting date:
December 2, 2014
Posting date:
December 2, 2014
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type II
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-42789

Recalled products

Mitoxantrone injection USP

Reason

Lot A024636AC did not meet the specification for the individual unknown impurity during the stability testing.

Depth of distribution

Retailers

Affected products

Mitoxantrone injection USP

DIN, NPN, DIN-HIM
DIN 02244614
Dosage form

Solution

Strength

2 mg/mL

Lot or serial number

A024636AC

Companies
Recalling Firm
Hospira Healthcare Corporation
Suite 600 - 1111 Dr. Frederik Philips Blvd
Saint-Laurent
H4M 1X6
Quebec
CANADA
Marketing Authorization Holder
Hospira Healthcare Corporation
Suite 600 - 1111 Dr. Frederik Philips Blvd
Saint-Laurent
H4M 1X6
Quebec
CANADA

Date modified: